Kerry Associates Inc. Receives LOI for $30 Million Dollar Financing on Behalf of Amelot Holdings Inc.
09 May 2006 - 3:15AM
Business Wire
Kerry Associates, Inc. announces that the company has received a
LOI for $30 Million Dollars in Financing on behalf of Amelot
Holdings, Inc. (Pink Sheets: AMHD). Based upon initial due
diligence and information provided to Remington Financial Group, a
letter of interest to Finance $30 million dollars for Amelots
Bio-Diesel division was received on Friday May 5th. Eric Cousens,
President of Kerry Associates stated "This is a non dilutive
financing. We have received numerous inquiries over the last few
weeks from investors, venture capitalist and joint venture
prospects since we started our campaign to raise capital for Amelot
Holdings. Our strategy is to put Amelot and its shareholders in the
forefront of the Bio-Diesel Industry. The progress being made has
exceeded all our expectations." About Amelot Holdings, Inc. Amelot
Holdings, Inc. is a diversified holding company focused on
acquiring under-valued, high-growth firms and properties in the
natural resource industry. For more information on Amelot Holdings
Inc. Visit: www.amelotholdings.com About Kerry Associates, Inc.
Kerry Associates Inc. is a business consulting firm helping
companies develop and expand into emerging markets while
strategically executing their objectives. For more information on
Kerry Associates Inc. Visit: www.kerryassociates.com Statements in
this press release that are not historical facts are
forward-looking statements within the meaning of the Securities Act
of 1933, as amended. Those statements include statements regarding
the intent, belief or current expectations of the Company and its
management. Such statements reflect management's current views, are
based on certain assumptions and involve risks and uncertainties.
Actual results, events, or performance may differ materially from
the above forward-looking statements due to a number of important
factors, and will be dependent upon a variety of factors,
including, but not limited to, our ability to obtain additional
financing and access funds from our existing financing arrangements
that will allow us to continue our current and future operations
and whether demand for our products and services in domestic and
international markets will continue to expand. The Company
undertakes no obligation to publicly update these forward-looking
statements to reflect events or circumstances that occur after the
date hereof or to reflect any change in the Company's expectations
with regard to these forward-looking statements or the occurrence
of unanticipated events.
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
From Nov 2024 to Dec 2024
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about HLK Biotech Holding Group Inc (CE) (OTCMarkets): 0 recent articles
More Kerry Associates, Inc. News Articles